REGARDS

Related by string. regarding * * Cautionary Note Regarding Forward . Legal Notice Regarding . highly regarded . Caution Regarding Forward Looking . Regarding Forward Looking Statements . INTENTIONS REGARDING THE FUTURE . lightly regarded . Cautionary Statement Regarding Forward . widely regarded . Widely regarded . regarding DOR BioPharma . Highly regarded *

Related by context. Frequent words. (Click for all words.) 63 substudy 62 Atherosclerosis Risk 61 PROVE IT 59 retrospective cohort study 58 prospective observational 56 Radiation Therapy Oncology 56 Multicenter 56 PREVAIL 56 multicenter study 55 COMPARE 55 atherothrombosis 55 MEDAL 54 prospective cohort 54 OBJECTIVES 54 REVIVE 54 SWOG 54 Cohort Study 53 prospective multicenter 53 multicentre 53 Phase III randomized 53 METHODS 53 Medical Expenditure Panel 52 Gynecologic Oncology Group 52 PRECISE 52 longitudinal study 52 COMPLIANCE 52 CONQUER 52 Rosuvastatin 52 multicenter randomized double 52 ENROLLMENT 52 NHANES III 52 placebo controlled clinical 52 multicenter clinical 52 ALLHAT 51 ACCLAIM 51 Thrombolysis 51 ADNI 51 multicenter 51 randomized clinical 51 Arch Intern Med 50 Health Initiative WHI 50 randomized controlled clinical 50 NHANES 50 STUDY 50 Kidney Diseases NIDDK 50 SYNTAX 50 Prospective Investigation 50 observational study 50 TRIUMPH 50 colorectal adenomas 50 COPAXONE R 50 patients undergoing percutaneous 50 TRITON TIMI 50 uncontrolled hypertension 50 pulmonary embolism PE 50 acute coronary syndromes ACS 50 blinded placebo controlled 49 Myocardial Infarction 49 randomized Phase III 49 EORTC 49 ASTHMA 49 acute myocardial infarction AMI 49 Renal Data 49 nondiabetic 49 BRFSS 49 genetic polymorphisms 49 myocardial infarction MI 49 PATENT 49 Systematic Review 49 Ischemic 49 Longitudinal Study 49 Interview Survey 49 ACTIVE 48 Catheterization 48 Glioma 48 End Results SEER 48 ENDEAVOR 48 Arch Neurol 48 ClinicalTrials.gov 48 Stroke NINDS 48 undergoing coronary artery 48 placebo controlled randomized 48 Diabetic Retinopathy 48 NAFLD 48 placebo controlled Phase 48 hepatitis C HCV 48 Atherosclerosis 48 CATIE 48 RECOVER 47 registrational 47 chronic HCV infection 47 Nationwide Inpatient Sample 47 vascular inflammation 47 Carotid 47 ADHF 47 randomized controlled trial 47 hepatocellular carcinoma HCC 47 #p# [001] 47 Solid Tumors 47 RTOG 47 phase IIb clinical

Back to home page